BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 202015)

  • 1. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats.
    Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P
    Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the immunoglobulin class of complement-dependent cytotoxic antibodies in serum of D23 hepatoma-bearing rats.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1980; 11(3):253-60. PubMed ID: 9537053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
    Abe S; Berczi I; Sehon AH
    Int J Cancer; 1977 Oct; 20(4):595-606. PubMed ID: 199549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas.
    Bowen JG; Baldwin RW
    Transplantation; 1976 Mar; 21(3):213-9. PubMed ID: 59982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.
    Baldwin RW; Bowen JG; Price MR
    Br J Cancer; 1973 Jul; 28(1):16-24. PubMed ID: 4353387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG; Robins RA; Baldwin RW
    Int J Cancer; 1975 Apr; 15(4):640-50. PubMed ID: 166943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
    Lando P; Berzins K; Gabriel J; Larsson P; Perlmann P
    Br J Cancer; 1981 Oct; 44(4):522-31. PubMed ID: 7295508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1982 Mar; 15(3):259-66. PubMed ID: 7089487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation immunity of rats induced by hepatoma cells treated with heteroantibody.
    El-Asfahani AM; Maruta H; Mizuno D; Ishidate M; Hashimoto Y; Nishioka K
    Gan; 1975 Feb; 66(1):1-9. PubMed ID: 169181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):382-93. PubMed ID: 4143271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor-specific cytotoxic and neutralizing factor in rats immunized with ascites hepatoma induced by azo dyes.
    El-Asfahani AM; Mizuno D; Hashimoto Y; Ishidate M; Nishioka K
    Gan; 1975 Feb; 66(1):11-9. PubMed ID: 168113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR; Höffken K; Baldwin RW
    Transplantation; 1979 Aug; 28(2):140-3. PubMed ID: 483360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10.
    Abe S; Berczi I; Sehon AH
    Int J Cancer; 1977 Jul; 20(1):137-45. PubMed ID: 198379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.
    Höffken K; Price MR; Moore VE; Baldwin RW
    Int J Cancer; 1978 Nov; 22(5):576-82. PubMed ID: 214404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of rat hepatoma membrane fractions.
    Baldwin RW; Embleton MJ; Moore M
    Br J Cancer; 1973 Nov; 28(5):389-99. PubMed ID: 4357132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma.
    Baldwin RW; Moore M
    Int J Cancer; 1969 Nov; 4(6):753-60. PubMed ID: 4314170
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas.
    Baldwin RW; Embleton MJ
    Int J Cancer; 1971 Jan; 7(1):17-25. PubMed ID: 4322936
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.
    Baldwin RW; Price MR; Robins RA
    Int J Cancer; 1973 May; 11(3):527-35. PubMed ID: 4364717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.